fda warning letter semaglutide october 2025 US warns online vendors to stop selling unapproved weight-loss drugs Hims & Hers' Woes Compound

GLP-1 drugs change a persons biochemistry, making them feel fuller longer and slowing digestion

10.1001/jama.1996.03530440029033 134 GrodinJ

Additionally, peptides that modulate immune responses may provide relief for autoimmune diseases and allergies, while their neuroprotective properties can support those with neurodegenerative diseases and inflammatory conditions

The FDA approval makes Epkinly the first T cell-engaging bispecific antibody for the subcutaneous treatment of relapsed or refractory follicular lymphoma, according to the partners

In conclusion, retatrutride and tirzepatide represent significant advancements in obesity therapeutics, each presenting distinct attributes and considerations for patients and healthcare providers, especially in the future if retatrutride hits the market